{"entity":{"type":"insider","cik":"0001953943","url":"/insider/0001953943","json_url":"/insider/0001953943.json","name":"Halladay Benjamin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2024-12-18","last":"2026-06-18","span_basis":"filed_date"},"name_variants":[{"name":"Halladay Benjamin","source":"filing","n_filings":11,"first_seen":"2024-12-18","last_seen":"2026-06-18"}],"transactions":[{"id":6113233,"accession":"0001628280-26-044264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-044264","line_url":"/filing/0001628280-26-044264#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10773.0,"shares_display":"10,773","price_per_share":3.155,"price_display":"3.16","price_state":"stated","total_value":33988.815,"total_display":"33,988.82","total_whole":"33,989","shares_owned_after":702829.0,"shares_owned_after_display":"702,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-18","scope":"insider"},{"id":6077246,"accession":"0001628280-26-019409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-019409","line_url":"/filing/0001628280-26-019409#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6424.0,"shares_display":"6,424","price_per_share":2.705,"price_display":"2.70","price_state":"stated","total_value":17376.92,"total_display":"17,376.92","total_whole":"17,377","shares_owned_after":713602.0,"shares_owned_after_display":"713,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-18","scope":"insider"},{"id":5096256,"accession":"0001628280-25-057942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-057942","line_url":"/filing/0001628280-25-057942#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7337.0,"shares_display":"7,337","price_per_share":3.667,"price_display":"3.67","price_state":"stated","total_value":26904.779,"total_display":"26,904.78","total_whole":"26,905","shares_owned_after":467525.0,"shares_owned_after_display":"467,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-18","scope":"insider"},{"id":4563146,"accession":"0001953943-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001953943-25-000004","line_url":"/filing/0001953943-25-000004#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7046.0,"shares_display":"7,046","price_per_share":2.808,"price_display":"2.81","price_state":"stated","total_value":19785.168,"total_display":"19,785.17","total_whole":"19,785","shares_owned_after":474862.0,"shares_owned_after_display":"474,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-18","scope":"insider"},{"id":4839894,"accession":"0001628280-25-035334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-035334","line_url":"/filing/0001628280-25-035334#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11.0,"shares_display":"11","price_per_share":1.115,"price_display":"1.12","price_state":"stated","total_value":12.265,"total_display":"12.26","total_whole":"12","shares_owned_after":474462.0,"shares_owned_after_display":"474,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-18","scope":"insider"},{"id":4929277,"accession":"0001628280-25-032217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-032217","line_url":"/filing/0001628280-25-032217#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7229.0,"shares_display":"7,229","price_per_share":1.152,"price_display":"1.15","price_state":"stated","total_value":8327.808,"total_display":"8,327.81","total_whole":"8,328","shares_owned_after":474473.0,"shares_owned_after_display":"474,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-18","scope":"insider"},{"id":4535908,"accession":"0001628280-25-018566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-018566","line_url":"/filing/0001628280-25-018566#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8.0,"shares_display":"8","price_per_share":0.964,"price_display":"0.96","price_state":"stated","total_value":7.712,"total_display":"7.71","total_whole":"8","shares_owned_after":481702.0,"shares_owned_after_display":"481,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-17","filed_date":"2025-04-21","scope":"insider"},{"id":4729193,"accession":"0001628280-25-013812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-013812","line_url":"/filing/0001628280-25-013812#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3535.0,"shares_display":"3,535","price_per_share":1.483,"price_display":"1.48","price_state":"stated","total_value":5242.405,"total_display":"5,242.40","total_whole":"5,242","shares_owned_after":481710.0,"shares_owned_after_display":"481,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-19","scope":"insider"},{"id":4204810,"accession":"0001628280-25-006801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-006801","line_url":"/filing/0001628280-25-006801#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11.0,"shares_display":"11","price_per_share":1.86,"price_display":"1.86","price_state":"stated","total_value":20.46,"total_display":"20.46","total_whole":"20","shares_owned_after":240671.0,"shares_owned_after_display":"240,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-20","scope":"insider"},{"id":4154766,"accession":"0001628280-25-002037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-002037","line_url":"/filing/0001628280-25-002037#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9.0,"shares_display":"9","price_per_share":2.265,"price_display":"2.26","price_state":"stated","total_value":20.385,"total_display":"20.38","total_whole":"20","shares_owned_after":240682.0,"shares_owned_after_display":"240,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":2705271,"accession":"0001628280-24-051875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-051875","line_url":"/filing/0001628280-24-051875#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001953943","owner_name":"Halladay Benjamin","owner_display_name":"Halladay Benjamin","owner_url":"/insider/0001953943","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3245.0,"shares_display":"3,245","price_per_share":2.424,"price_display":"2.42","price_state":"stated","total_value":7865.88,"total_display":"7,865.88","total_whole":"7,866","shares_owned_after":240691.0,"shares_owned_after_display":"240,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Officer (Chief Financial Officer)","n_filings":11,"first_seen":"2024-12-18","last_seen":"2026-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001953943","retrieved_at":"2026-08-27T03:19:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}